{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:45:08Z","timestamp":1763700308544,"version":"3.45.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Mashhad University of Medical Sciences and Islamic Azad University","award":["4021693"],"award-info":[{"award-number":["4021693"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05544-7","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:40:10Z","timestamp":1763700010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Administration of Cilostazol Mitigates Learning and Memory Disturbance in a Rat Model of Amnesia by Modifying Cholinergic Function and Neuroinflammation"],"prefix":"10.1007","volume":"63","author":[{"given":"Sakineh Sadat Mortazavi","family":"Sani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Eidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Rajabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"1","key":"5544_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11033-025-10463-w","volume":"52","author":"N Ali","year":"2025","unstructured":"Ali N, Sayeed U, Shahid SMA, Akhtar S, Khan MKA (2025) Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review. Mol Biol Rep 52(1):337. https:\/\/doi.org\/10.1007\/s11033-025-10463-w","journal-title":"Mol Biol Rep"},{"key":"5544_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102667","volume":"104","author":"P Wen","year":"2025","unstructured":"Wen P, Sun Z, Gou F, Wang J, Fan Q, Zhao D et al (2025) Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders. Ageing Res Rev 104:102667. https:\/\/doi.org\/10.1016\/j.arr.2025.102667","journal-title":"Ageing Res Rev"},{"key":"5544_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejmech.2018.09.031","volume":"158","author":"Q Li","year":"2018","unstructured":"Li Q, He S, Chen Y, Feng F, Qu W, Sun H (2018) Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer\u2019s disease. Eur J Med Chem 158:463\u2013477. https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.031","journal-title":"Eur J Med Chem"},{"issue":"7","key":"5544_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28581","volume":"10","author":"S Liu","year":"2024","unstructured":"Liu S, Wang M, Xiao H, Ye J, Cao L, Li W et al (2024) Advancements in research on the effects of panax notoginseng saponin constituents in ameliorating learning and memory disorders. Heliyon 10(7):e28581. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28581","journal-title":"Heliyon"},{"key":"5544_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05223-7","author":"HS Ryu","year":"2025","unstructured":"Ryu HS, Sanjay Choi SK, Lee KH, Jang SS, Yang SY, Kwon YS et al (2025) Golden oyster mushroom extract ameliorates oxidative stress-induced cell death in neurons and scopolamine-induced cholinergic system impairment in mice. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05223-7","journal-title":"Mol Neurobiol"},{"issue":"8","key":"5544_CR6","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1007\/s12035-021-02358-1","volume":"58","author":"E Sohn","year":"2021","unstructured":"Sohn E, Kim YJ, Kim JH, Jeong SJ (2021) Ficus erecta Thunb leaves alleviate memory loss induced by scopolamine in mice via regulation of oxidative stress and cholinergic system. Mol Neurobiol 58(8):3665\u20133676. https:\/\/doi.org\/10.1007\/s12035-021-02358-1","journal-title":"Mol Neurobiol"},{"key":"5544_CR7","doi-asserted-by":"publisher","first-page":"1607289","DOI":"10.3389\/fnagi.2025.1607289","volume":"17","author":"W Ahmad","year":"2025","unstructured":"Ahmad W, Choe K, Ahmad R, Park TJ, Kim MO (2025) Ambroxol confers neuroprotection against scopolamine-induced Alzheimer\u2019s-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2\/JNK\/GSK-3\u03b2 signaling pathways. Front Aging Neurosci 17:1607289. https:\/\/doi.org\/10.3389\/fnagi.2025.1607289","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"5544_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09295","volume":"8","author":"MJ Hosseini","year":"2022","unstructured":"Hosseini MJ, Mahmoodi N, Eskandari J, Bijani S, Yazdinezhad AR, Anoush M (2022) Protective effects of Vinca herbaceous extract against scopolamine-induced behavioral disturbances and brain oxidative stress in rats. Heliyon 8(4):e09295. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09295","journal-title":"Heliyon"},{"issue":"4","key":"5544_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10557-021-07187-x","volume":"36","author":"RY Kherallah","year":"2022","unstructured":"Kherallah RY, Khawaja M, Olson M, Angiolillo D, Birnbaum Y (2022) Cilostazol: a review of basic mechanisms and clinical uses. Cardiovasc Drugs Ther 36(4):777\u2013792. https:\/\/doi.org\/10.1007\/s10557-021-07187-x","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"5544_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12028-022-01637-6","volume":"38","author":"AI Qureshi","year":"2023","unstructured":"Qureshi AI, Akhtar IN, Ma X, Lodhi A, Bhatti I, Beall J et al (2023) Effect of cilostazol in animal models of cerebral ischemia and subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care 38(3):698\u2013713. https:\/\/doi.org\/10.1007\/s12028-022-01637-6","journal-title":"Neurocrit Care"},{"issue":"1","key":"5544_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/3465757","volume":"2024","author":"DA El-ezz","year":"2024","unstructured":"El-ezz DA, Aldahmash W, Esatbeyoglu T, Afifi SM, Elbaset MA (2024) Cilostazol combats lipopolysaccharide-induced hippocampal injury in rats: role of AKT\/GSK3\u03b2\/CREB curbing neuroinflammation. Adv Pharmacol Pharm Sci 2024(1):3465757. https:\/\/doi.org\/10.1155\/2024\/3465757","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"5544_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109986","volume":"117","author":"RM El-Sayed","year":"2023","unstructured":"El-Sayed RM, Abdelaziz AM, Zaki HF, Abdel Rasheed NO (2023) Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson\u2019s disease in rats: correlation between Nrf2 and HMGB1\/TLR4\/PI3K\/Akt\/mTOR signaling. Int Immunopharmacol 117:109986. https:\/\/doi.org\/10.1016\/j.intimp.2023.109986","journal-title":"Int Immunopharmacol"},{"key":"5544_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177194","volume":"987","author":"ES Gad","year":"2025","unstructured":"Gad ES, Aldossary SA, El-Ansary MR, Abd El-Galil MM, Abd-El-Hamid AH, El-Ansary AR et al (2025) Cilostazol counteracts mitochondrial dysfunction in hepatic encephalopathy rat model: insights into the role of cAMP\/AMPK\/SIRT1\/ PINK-1\/parkin hub and p-CREB \/BDNF\/ TrkB neuroprotective trajectory. Eur J Pharmacol 987:177194. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177194","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"5544_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10787-022-00971-7","volume":"30","author":"M Akbarian","year":"2022","unstructured":"Akbarian M, Mirzavi F, Amirahmadi S, Hosseini M, Alipour M, Feizi H et al (2022) Amelioration of oxidative stress, cholinergic dysfunction, and neuroinflammation in scopolamine-induced amnesic rats fed with pomegranate seed. Inflammopharmacology 30(3):1021\u20131035. https:\/\/doi.org\/10.1007\/s10787-022-00971-7","journal-title":"Inflammopharmacology"},{"issue":"12","key":"5544_CR15","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1007\/s12035-022-03024-w","volume":"59","author":"OS Zaki","year":"2022","unstructured":"Zaki OS, Nassar NN, Abdallah DM, Safar MM, Mohammed RA (2022) Cilostazol alleviates NLRP3 inflammasome-induced allodynia\/hyperalgesia in murine cerebral cortex following transient ischemia: focus on TRPA1\/glutamate and Akt\/dopamine\/BDNF\/Nrf2 trajectories. Mol Neurobiol 59(12):7194\u20137211. https:\/\/doi.org\/10.1007\/s12035-022-03024-w","journal-title":"Mol Neurobiol"},{"issue":"6","key":"5544_CR16","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s10787-022-01010-1","volume":"30","author":"M Khalifa","year":"2022","unstructured":"Khalifa M, Abdelsalam RM, Safar MM, Zaki HF (2022) Phosphodiesterase (PDE) III inhibitor, cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP\/CREB pathway. Inflammopharmacology 30(6):2477\u20132488. https:\/\/doi.org\/10.1007\/s10787-022-01010-1","journal-title":"Inflammopharmacology"},{"issue":"7","key":"5544_CR17","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1007\/s12035-016-0051-8","volume":"54","author":"AM El-Dessouki","year":"2017","unstructured":"El-Dessouki AM, Galal MA, Awad AS, Zaki HF (2017) Neuroprotective effects of simvastatin and cilostazol in l-methionine-induced vascular dementia in rats. Mol Neurobiol 54(7):5074\u20135084. https:\/\/doi.org\/10.1007\/s12035-016-0051-8","journal-title":"Mol Neurobiol"},{"issue":"8","key":"5544_CR18","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.3390\/nu13082890","volume":"13","author":"JH Choi","year":"2021","unstructured":"Choi JH, Lee EB, Jang HH, Cha YS, Park YS, Lee SH (2021) Allium hookeri extracts improve scopolamine-induced cognitive impairment via activation of the cholinergic system and anti-neuroinflammation in mice. Nutrients 13(8):2890. https:\/\/doi.org\/10.3390\/nu13082890","journal-title":"Nutrients"},{"issue":"3","key":"5544_CR19","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/s10753-024-02133-z","volume":"48","author":"L Zhang","year":"2025","unstructured":"Zhang L, Jiang Z, Hu S, Ni H, Zhao Y, Tan X et al (2025) GSK3\u03b2 substrate-competitive inhibitors regulate the gut homeostasis and barrier function to inhibit neuroinflammation in scopolamine-induced Alzheimer\u2019s disease model mice. Inflammation 48(3):1438\u20131459. https:\/\/doi.org\/10.1007\/s10753-024-02133-z","journal-title":"Inflammation"},{"issue":"1","key":"5544_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/0118715273309256240702053609","volume":"24","author":"S Abidar","year":"2025","unstructured":"Abidar S, Hritcu L, Nhiri M (2025) An overview of the natural neuroprotective agents for the management of cognitive impairment induced by scopolamine in zebrafish (Danio rerio). CNS & Neurological Disorders 24(1):21\u201331. https:\/\/doi.org\/10.2174\/0118715273309256240702053609","journal-title":"CNS & Neurological Disorders"},{"issue":"3","key":"5544_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1538\/expanim.21-0120","volume":"71","author":"MZ Othman","year":"2022","unstructured":"Othman MZ, Hassan Z, Che Has AT (2022) Morris water maze: a versatile and pertinent tool for assessing spatial learning and memory. Exp Anim 71(3):264\u2013280. https:\/\/doi.org\/10.1538\/expanim.21-0120","journal-title":"Exp Anim"},{"issue":"3","key":"5544_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11011-017-9954-y","volume":"32","author":"F Beheshti","year":"2017","unstructured":"Beheshti F, Karimi S, Vafaee F, Shafei MN, Sadeghnia HR, Hadjzadeh MAR, Hosseini M (2017) The effects of vitamin C on hypothyroidism-associated learning and memory impairment in juvenile rats. Metab Brain Dis 32(3):703\u2013715. https:\/\/doi.org\/10.1007\/s11011-017-9954-y","journal-title":"Metab Brain Dis"},{"key":"5544_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.nlm.2013.07.006","volume":"106","author":"AK Wagner","year":"2013","unstructured":"Wagner AK, Brayer SW, Hurwitz M, Niyonkuru C, Zou H, Failla M (2013) Non-spatial pre-training in the water maze as a clinically relevant model for evaluating learning and memory in experimental TBI. Neurobiol Learn Mem 106:71\u201386. https:\/\/doi.org\/10.1016\/j.nlm.2013.07.006","journal-title":"Neurobiol Learn Mem"},{"key":"5544_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/srat\/6893801","volume":"2025","author":"R Ravi","year":"2025","unstructured":"Ravi R, Das S, Hakami T, BMP, Pushparajan L (2025) Pharmacotherapy for poststroke cognitive impairment and poststroke cognitive impairment with dementia: a review. Stroke Res Treat 2025:6893801. https:\/\/doi.org\/10.1155\/srat\/6893801","journal-title":"Stroke Res Treat"},{"key":"5544_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.742065","volume":"15","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G (2021) Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci 15:742065. https:\/\/doi.org\/10.3389\/fnins.2021.742065","journal-title":"Front Neurosci"},{"issue":"1","key":"5544_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2008.05.013","volume":"130","author":"J Jinno","year":"2008","unstructured":"Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M et al (2008) In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Control Release 130(1):29\u201337. https:\/\/doi.org\/10.1016\/j.jconrel.2008.05.013","journal-title":"J Control Release"},{"issue":"2","key":"5544_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/gels11020082","volume":"11","author":"M Salamah","year":"2025","unstructured":"Salamah M, Budai-Sz\u0171cs M, Sipos B, Volk B, Katona G, Balogh GT, Cs\u00f3ka I (2025) Development and characterization of in situ gelling nasal cilostazol spanlastics. Gels 11(2):82. https:\/\/doi.org\/10.3390\/gels11020082","journal-title":"Gels"},{"issue":"4","key":"5544_CR28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/nano11041009","volume":"11","author":"H Otake","year":"2021","unstructured":"Otake H, Yamaguchi M, Ogata F, Deguchi S, Yamamoto N, Sasaki H et al (2021) Transdermal system based on solid Cilostazol nanoparticles attenuates ischemia\/reperfusion-induced brain injury in mice. Nanomaterials 11(4):1009. https:\/\/doi.org\/10.3390\/nano11041009","journal-title":"Nanomaterials"},{"key":"5544_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116190","volume":"171","author":"H Ni","year":"2024","unstructured":"Ni H, Liu M, Cao M, Zhang L, Zhao Y, Yi L et al (2024) Sinomenine regulates the cholinergic anti-inflammatory pathway to inhibit TLR4\/NF-\u03baB pathway and protect the homeostasis in brain and gut in scopolamine-induced Alzheimer\u2019s disease mice. Biomed Pharmacother 171:116190. https:\/\/doi.org\/10.1016\/j.biopha.2024.116190","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"5544_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint17050069","volume":"17","author":"C Anastasiadou","year":"2025","unstructured":"Anastasiadou C, Papapetrou A, Galyfos G, Vekrellis K, Katafygiotis P, Lazaris A et al (2025) Effect of cilostazol and aspirin during hyperacute stroke phase in rats: an experimental research study. Neurol Int 17(5):69. https:\/\/doi.org\/10.3390\/neurolint17050069","journal-title":"Neurol Int"},{"key":"5544_CR31","doi-asserted-by":"publisher","first-page":"1031637","DOI":"10.3389\/fphar.2022.1031637","volume":"13","author":"S Yanai","year":"2022","unstructured":"Yanai S, Tago T, Toyohara J, Arasaki T, Endo S (2022) Reversal of spatial memory impairment by phosphodiesterase 3 inhibitor cilostazol is associated with reduced neuroinflammation and increased cerebral glucose uptake in aged male mice. Front Pharmacol 13:1031637. https:\/\/doi.org\/10.3389\/fphar.2022.1031637","journal-title":"Front Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05544-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:40:11Z","timestamp":1763700011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05544-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5544"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05544-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"112"}}